Development and full validation of six inhibition assays for five major cytochrome P450 enzymes in human liver microsomes using an automated 96-well microplate incubation format and LC–MS/MS analysis

This publication has 30 references indexed in Scilit:

• Enzyme Kinetics of Cytochrome P450-Mediated Reactions
  Current Drug Metabolism, 2012
• FLUORESCENCE-BASED ASSAYS FOR SCREENING NINE CYTOCHROME P450 (P450) ACTIVITIES IN INTACT CELLS EXPRESSING INDIVIDUAL HUMAN P450 ENZYMES
  Drug Metabolism and Disposition, 2004
• High‐throughput cytochrome P450 inhibition assays by ultrafast gradient liquid chromatography with tandem mass spectrometry using monolithic columns
  Rapid Communications in Mass Spectrometry, 2003
• Evaluation of Cytochrome P450 Probe Substrates Commonly Used by the Pharmaceutical Industry to Study in Vitro Drug Interactions
  Drug Metabolism and Disposition, 2002
• Cytochrome P450 Fluorometric Substrates: Identification of Isoform-Selective Probes for Rat CYP2D2 and Human CYP3A4.
  Drug Metabolism and Disposition, 2002
• Validation of higher‐throughput high‐performance liquid chromatography/atmospheric pressure chemical ionization tandem mass spectrometry assays to conduct cytochrome P450s CYP2D6 and CYP3A4 enzyme inhibition studies in human liver microsomes
  Rapid Communications in Mass Spectrometry, 2000
• Drug-drug interactions of new active substances: mibefradil example
  European Journal of Clinical Pharmacology, 1999
• Incidence of Adverse Drug Reactions in Hospitalized Patients
  JAMA, 1998
• Application of a generic fast gradient liquid chromatography tandem mass spectrometry method for the analysis of cytochrome P450 probe substrates
  Rapid Communications in Mass Spectrometry, 1998
• P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature
  Pharmacogenetics, 1996